Original Article
The value of using fludeoxyglucose positron-emission tomography scan with respect to colorectal abnormalities—a cross-sectional study
Journal of Gastrointestinal Oncology
2019;
10
(1)
:1-5
.
(01 February 2019)
T4N0 colon cancers should be treated like T3N1 disease
Journal of Gastrointestinal Oncology
2019;
10
(1)
:6-11
.
(01 February 2019)
Staging and survival of colorectal cancer (CRC) in octogenarians: Nationwide Study of US Veterans
Journal of Gastrointestinal Oncology
2019;
10
(1)
:12-18
.
(01 February 2019)
Low prevalence of deficient mismatch repair (dMMR) protein in locally advanced rectal cancers (LARC) and treatment outcomes
Journal of Gastrointestinal Oncology
2019;
10
(1)
:19-29
.
(01 February 2019)
Colon cancer laterality is associated with atherosclerosis and coronary artery disease
Journal of Gastrointestinal Oncology
2019;
10
(1)
:30-36
.
(01 February 2019)
Racial and gender disparities in the incidence of anal cancer: analysis of the Nationwide Inpatient Sample (NIS)
Journal of Gastrointestinal Oncology
2019;
10
(1)
:37-41
.
(01 February 2019)
Lower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance
Journal of Gastrointestinal Oncology
2019;
10
(1)
:42-47
.
(01 February 2019)
Treatment outcomes of patients with localized anal squamous cell carcinoma according to HIV infection: systematic review and meta-analysis
Journal of Gastrointestinal Oncology
2019;
10
(1)
:48-60
.
(01 February 2019)
Curative treatment for metastatic colorectal cancer in the young population: is it worth it?
Journal of Gastrointestinal Oncology
2019;
10
(1)
:61-67
.
(01 February 2019)
Investigation of the changes in the expression levels of MOZ gene in colorectal cancer tissues
Journal of Gastrointestinal Oncology
2019;
10
(1)
:68-73
.
(01 February 2019)
Treatment disparities affect outcomes for patients with stage I esophageal cancer: a national cancer data base analysis
Journal of Gastrointestinal Oncology
2019;
10
(1)
:74-84
.
(01 February 2019)
Gastric squamous cell carcinoma and gastric adenosquamous carcinoma, clinical features and outcomes of rare clinical entities: a National Cancer Database (NCDB) analysis
Journal of Gastrointestinal Oncology
2019;
10
(1)
:85-94
.
(01 February 2019)
What to expect with major vascular reconstruction during Whipple procedures: a single institution experience and literature review
Journal of Gastrointestinal Oncology
2019;
10
(1)
:95-102
.
(01 February 2019)
Survival and prognostic factors analysis of 151 intestinal and pancreatic neuroendocrine tumors: a single center experience
Journal of Gastrointestinal Oncology
2019;
10
(1)
:103-111
.
(01 February 2019)
A phase I trial of Proton stereotactic body radiation therapy for liver metastases
Journal of Gastrointestinal Oncology
2019;
10
(1)
:112-117
.
(01 February 2019)
Outcomes and toxicity following Yttrium-90 radioembolization for hepatic metastases from neuroendocrine tumors—a singleinstitution experience
Journal of Gastrointestinal Oncology
2019;
10
(1)
:118-127
.
(01 February 2019)
Multimodality management of incidentally detected gall bladder cancer: long term results from a tertiary care cancer centre
Journal of Gastrointestinal Oncology
2019;
10
(1)
:128-133
.
(01 February 2019)
Review Article
Prognostic value of multiple cytokine analysis in colorectal cancer: a systematic review
Journal of Gastrointestinal Oncology
2019;
10
(1)
:134-143
.
(01 February 2019)
Gastrointestinal stromal tumors: a comprehensive review
Journal of Gastrointestinal Oncology
2019;
10
(1)
:144-154
.
(01 February 2019)
Case Report
Novel use of proton beam therapy for neoadjuvant treatment of radiation-associated squamous cell carcinoma of the esophagus
Journal of Gastrointestinal Oncology
2019;
10
(1)
:155-160
.
(01 February 2019)
Complete response to pembrolizumab in a patient with metastatic colon cancer with microsatellite instability and a history of Guillain-Barre syndrome
Journal of Gastrointestinal Oncology
2019;
10
(1)
:161-165
.
(01 February 2019)
